| __timestamp | Alpine Immune Sciences, Inc. | CRISPR Therapeutics AG |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 1513000 |
| Thursday, January 1, 2015 | 16054000 | 12573000 |
| Friday, January 1, 2016 | 23316000 | 42238000 |
| Sunday, January 1, 2017 | 10626000 | 69800000 |
| Monday, January 1, 2018 | 28970000 | 113773000 |
| Tuesday, January 1, 2019 | 35847000 | 179362000 |
| Wednesday, January 1, 2020 | 27185000 | 266946000 |
| Friday, January 1, 2021 | 58742000 | 438633000 |
| Saturday, January 1, 2022 | 70243000 | 461645000 |
| Sunday, January 1, 2023 | 80904000 | 387332000 |
| Monday, January 1, 2024 | 320653000 |
Cracking the code
In the ever-evolving landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Alpine Immune Sciences, Inc. and CRISPR Therapeutics AG have been at the forefront of this race.
From 2014 to 2023, CRISPR Therapeutics AG has consistently outpaced Alpine Immune Sciences in R&D expenditure. In 2023, CRISPR's R&D spending was nearly five times that of Alpine, highlighting its aggressive investment strategy. However, Alpine has shown remarkable growth, with its R&D expenses increasing by over 560% since 2014.
As these companies continue to push the boundaries of scientific discovery, their R&D investments will play a pivotal role in shaping the future of biotechnology. The data underscores the dynamic nature of the industry and the relentless pursuit of innovation.
Research and Development: Comparing Key Metrics for Johnson & Johnson and Alpine Immune Sciences, Inc.
Research and Development Expenses Breakdown: Novartis AG vs CRISPR Therapeutics AG
Research and Development Investment: Amgen Inc. vs Alpine Immune Sciences, Inc.
R&D Insights: How Amgen Inc. and CRISPR Therapeutics AG Allocate Funds
Comparing Innovation Spending: Sanofi and CRISPR Therapeutics AG
GSK plc or CRISPR Therapeutics AG: Who Invests More in Innovation?
Research and Development Investment: Bio-Techne Corporation vs CRISPR Therapeutics AG
Analyzing R&D Budgets: BioMarin Pharmaceutical Inc. vs Alpine Immune Sciences, Inc.
Research and Development Investment: Exelixis, Inc. vs Alpine Immune Sciences, Inc.
R&D Spending Showdown: Corcept Therapeutics Incorporated vs CRISPR Therapeutics AG
Comparing Innovation Spending: CymaBay Therapeutics, Inc. and CRISPR Therapeutics AG
R&D Insights: How CRISPR Therapeutics AG and Soleno Therapeutics, Inc. Allocate Funds